Bulgaria
EU
Europe
Italy
Russia
Serbia
Turkey
Companies
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Business briefing
CBD supplier Kannaway says it has been granted licences confirming compliance with the law and permitting free sale of a product in an EU member state – Bulgaria – as well as in Russia
Mexico
North America
Policy and Politics
Regulation and Legislation
Regulatory briefing
The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate
Asia
California
Europe
Germany
Italy
New Jersey
North America
South Dakota
Spain
Thailand
United Kingdom
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey
England
Europe
United Kingdom
Policy and Politics
Public Health and Medicine
Business briefing
The panel responsible for recommending which drugs England’s National Health Service (NHS) should prescribe may recommend against the organisation using cannabis-based medical products.
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory trackers
Welcome to the beta CBD-Intel US Regulatory tracker, updated each month. Within this interactive map gain insight into the proposed bills for all of the US states (excl. Hawaii). This map focuses exclusively on state law; federal, local and enacted laws are not considered, however for more information see our regulatory reports, or use our advanced search to select specific areas of […]
Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Lesotho
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Companies
Policy and Politics
Regulation and Legislation
Regulatory trackers
Use our newly updated directory of stakeholders in the global CBD sector to find the most relevant organisations in key markets, with full Web, email, phone and address details. Available exclusively to CBD-Intel subscribers, this once-yearly updated database is a consoldated, user-friendly Excel file. Note that this file is password protected; please enter the password: […]
Australasia
Australia
Canada
EU
Europe
North America
United States
Companies
Marketing and Retailing
Policy and Politics
Technology and Innovation
Business briefing
The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel’s weekly News In Brief.
Africa
Canada
Colombia
EU
Europe
Mexico
North America
South America
United States
Zimbabwe
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe
Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory trackers
Welcome to the CBD-Intel global regulatory tracker, updated each month. Use the tabs at the top of the map to select a specific regulatory field. Clicking on an individual country will bring up much more detail in the panel below, including links to legislation and CBD-Intel coverage of that market. Updates for August 2019: New […]
Africa
Arizona
Canada
EU
Europe
Germany
Italy
Luxemburg
Netherlands
North America
North Carolina
Ohio
South Africa
South Carolina
Spain
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa
EU
Europe
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
North America
United States
Companies
Policy and Politics
Regulation and Legislation
Business briefing
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
Belgium
Europe
Germany
Italy
North America
North Dakota
United Kingdom
United States
Companies
Policy and Politics
Regulation and Legislation
Regulatory briefing
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
Asia
California
China
Czech Republic
EU
Europe
France
Germany
Ireland
Italy
Latvia
North America
Ohio
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise
Australasia
Delaware
Europe
Italy
Kentucky
New Zealand
North America
South Dakota
Turkey
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam
Europe
United Kingdom
Policy and Politics
Public Health and Medicine
Regulatory briefing
The UK Centre for Medical Cannabis (CMC) has called for a Cannabinoid Clinical Trials Authority to regulate and test cannabis-based medicinal products
Argentina
Estonia
Europe
Iowa
Lithuania
North America
South America
Turkey
United States
Companies
Policy and Politics
Regulation and Legislation
Regulatory briefing
An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa
Europe
Germany
Companies
Policy and Politics
Regulation and Legislation
Regulatory reports
A German CBD company claims it can’t sell 90% of its stock following action by local authorities, while others are said to be facing charges of involvement in the illegal drug trade
Europe
United Kingdom
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
A group of British MPs is recommending that more trials and research are carried out into cannabis-based medical products (CBMPs), including those containing CBD
Canada
North America
Policy and Politics
Regulation and Legislation
Regulatory briefing
The Canadian government has taken a first step towards allowing health products containing CBD – and potentially other cannabinoids – without a prescription
Canada
North America
Policy and Politics
Regulation and Legislation
Business briefing
Smaller CBD stakeholders should not fear the entrance of big business into the market, according to one expert who explains how larger firms can help ease the regulatory path
Belgium
Colombia
Europe
Florida
France
Latvia
Massachusetts
New Mexico
North America
North Dakota
Oregon
South America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from around the US, Belgium, France, Latvia, and Colombia
Asia
China
Policy and Politics
Regulation and Legislation
Regulatory reports
As regulations in China continue to evolve, we look at developments in the third Chinese province to consider new regulations for industrialised hemp
Africa
South Africa
Policy and Politics
Regulation and Legislation
Regulatory briefing
A landmark decision by South Africa’s now former health minister Aaron Motsoledi has legalised lower dosage CBD. But there’s a catch – the ruling only applies until May 2020
EU
Europe
France
Companies
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Business briefing
The number of French CBD shops reopening after facing legal action continues to rise, with at least seven shopkeepers acquitted of charges against them
Canada
North America
Policy and Politics
Regulation and Legislation
Regulatory reports
Canada is the centre for the world’s largest cannabis companies and has recently implemented a wide-ranging new regulatory environment for all cannabis products
Europe
United Kingdom
Companies
Policy and Politics
Business briefing
British national newspapers have run nearly 300 articles related to CBD over the last year – and the lion’s share have been overwhelmingly positive
Europe
United Kingdom
Policy and Politics
Public Health and Medicine
Regulatory briefing
International cannabis company Tilray has denied an accusation by the British Paediatric Neurological Association that it failed to provide sample products for testing
North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
A meeting between the US FDA and members of the CBD industry provided the agency with plenty of information, but threw little light on the path it is likely to take
Florida
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory reports
As part of our ongoing series of concise reports on how CBD is regulated across the US, we look at Florida – where a new law is on the way
North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing
CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American football.
Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North America
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
United States
Utah
Vermont
Virginia
Washington
Washington D.C.
West Virginia
Wisconsin
Wyoming
Policy and Politics
Regulation and Legislation
Regulatory briefing
Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform
Canada
Colorado
Europe
Indiana
North America
Puerto Rico
Spain
United Kingdom
United States
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Europe
Policy and Politics
Regulation and Legislation
Regulatory briefing
Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation
Asia
Canada
India
North America
World
Companies
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory briefing
The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station
Belgium
Czech Republic
EU
Europe
Germany
Lithuania
Netherlands
Switzerland
Policy and Politics
Regulation and Legislation
Regulatory briefing
The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU
North America
Tennessee
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
The Tennessee legislature has enacted a bill which defines “smoking hemp”
Europe
Ireland
Companies
Policy and Politics
Business briefing
Funding is available for Irish CBD businesses from Enterprise Ireland, a government body facilitating business development
Europe
Italy
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory briefing
The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry
North America
United States
Companies
Policy and Politics
Regulation and Legislation
Business briefing
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal
Australasia
New Zealand
Policy and Politics
Regulation and Legislation
Regulatory briefing
A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD
North America
United States
Policy and Politics
Public Health and Medicine
Regulatory briefing
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis
France
North America
United Kingdom
United States
Policy and Politics
Public Health and Medicine
Business briefing
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment
Europe
Ireland
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
United Kingdom
Policy and Politics
Public Health and Medicine
Regulatory briefing
A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families